Pie Medical Imaging congratulates Dr. Rodrigo Modolo and the whole academic team lead by Prof. Serruys with the presentation of ASSESS-REGURGE as late breaking trial at EuroPCR. Parallel to the presentation, ASSESS-REGURGE has been published in EuroIntervention: This landmark multi-center study has demonstrated the high feasibility of quantitative aortography (CAAS A-Valve) using protocoled acquisition.

Join us at EuroPCR 2019! (May 2019)

Please join us for a very exciting EuroPCR conference to see our innovative applications in action. Our global team welcomes you to booth M5 to see the latest versions of CAAS and 3mensio. Additionally please join us during the following sessions. CAAS vFFR Wednesday May 22nd (Room 353) 14:58 The impact of vFFR on heart […]


Name Place Date
ESPR Helsinki, FI May 16 - 18
EuroPCR Paris, FR May 20 - 24
TVT Chicago, IL June 12 - 15

The CAAS brand offers a broad product range for diagnosis and planning of treatment of coronary arteries, heart chambers and peripheral vessels in X-ray, MRI, IVUS and OCT images.

The 3mensio brand offers a broad product range for the planning of procedures, sizing and visualization in CT images.